Strides Pharma Scien Share Price

Strides Pharma Scien (INR)1630.9565   (4.2%)

Exchange ScripsBSE532531NSESTARISININE939A01011

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Strides Pharma Scien Performance

Market performance
Open price1575
High1653.45
Volumes646346
Prev Close1630.95
Low1549.25
Closing date2024-10-16
Historical performance
1 Year High1653.45
3 Year High1653.45
5 Year High1653.45
1 Year Low467.00
3 Year Low263.35
5 Year Low263.35

Strides Pharma Scien Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
14465
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
-203.8
Dividend Yield
Dividend Yield
0.02 %

Strides Pharma Scien Investment Returns

1 Year
206.9%
3 Years
164.2%
5 Years
340.4%
10 Years
96.5%

Strides Pharma Scien Technicals

IndicatorsValueSignal
5-DMA1567.59Bullish
10-DMA1508Bullish
20-DMA1439.65Bullish
50-DMA1349.24Bullish
100-DMA1145.66Bullish
200-DMA964.1Bullish

Shareholding Pattern

FieldJun-2024Mar-2024Dec-2023Sep-2023Jun-2023
Promoters1515161616
Foreign Investors------------1
Domestic Investors1515161615
Public Investors919028468091166101622112759
Government11111

Strides Pharma Scien Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income49813521334594
Operating Profit7830520511196863
Interest3144261117671501
Depreciation2207243323302063
Profit Before Tax-1169-2862-65252754
Consolidated Net Profit-706-2026-46022684
Adjusted EPS-8-22-5130

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital919903898897
Total Reserves20306210252267026823
Minority Interest-539-394241373
Total Non-Current Liabilities621412103965712644
Total Liabilities55724637346760768168
Capital Work in Progress7994835622276
Total Assets55724637346760768168

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities7011444-25784814
Cash Flow from Investing Activities-15023025-1187-5208
Cash Flow from Financing Activitie-6933-21394213-158
Net Cash Inflow / Outflow-14251330448-552
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of -203.8.
  • 3Y Stock Price CAGR of the stock is 39.2.
  • The stock has a beta of 0.6.
  • In the last financial year, the company had an EBITDA of ₹7830 Million.
  • The company generated revenue of ₹40511 Million in the previous financial year.

Strides Pharma Scien

1630.9565   (4.2%)

Investment Amount: ₹ 51905
Current Value: ₹ 163095
Performence: 214.2%
P/L: ₹ 111190
Top Gainers
SymbolChange%
PREMIERPOL332.18(20%)
VAISHALI21.97(20%)
ANGELONE3236(18%)
AJMERA830.7(16%)
MOTILALOFS962.05(12%)
Top Losers
SymbolChange%
HAVISHA2.64(-8%)
SOMATEX45.58(-7%)
SHANTI17.37(-7%)
WEL1491.9(-6%)
ORIENTLTD114.7(-6%)
DBCORP333.35(-6%)
DELTAMAGNT98.78(-6%)
AKSHAR1.29(-6%)
Similar stocks

Neuland Laboratories

25

16250.7

September 16 - October 16

RPG Life Sciences

24.2

2818.8

September 16 - October 16

Vaishali Pharma

20.2

21.97

September 16 - October 16

Medicamen Biotech

17.4

531.4

September 16 - October 16

Ipca Laboratories

15.5

1655.65

September 16 - October 16

Unichem Lab

13.9

727.1

September 16 - October 16

Astrazeneca Pharma I

12

7649.75

September 16 - October 16

Jagsonpal Pharma

11.4

449.4

September 16 - October 16

Announcing Stock of the Month!

Stock of the Month
Stock of the Month